EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity



Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity



Medical Journal of Australia 1(11): 549-550



A questionnaire was mailed to 3000 medical practitioners throughout Australia to assess attitudes to cardiac failure therapy. The proportion of responses suitable for analysis was 31%. There was a preference for initiating treatment with a diuretic rather than digoxin and for commencing digoxin in daily maintenance dosage rather than with a loading dose. Two-thirds of the doctors surveyed regulated glycoside therapy by monitoring blood digoxin levels. The answer pattern suggested digoxin level measurement had influenced diagnosis of toxicity.

(PDF emailed within 1 workday: $29.90)

Accession: 006550755

Download citation: RISBibTeXText

PMID: 7393042



Related references

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity. Quarterly Journal of Medicine 47(186): 111-122, 1978

Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Therapeutic Drug Monitoring 22(2): 163-168, 2000

Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Medical Journal of Australia 174(9): 439-444, 2001

Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin. Fortschritte der Medizin 98(11):, 1980

Frontiers in congestive heart failure: Digoxin toxicity: an evaluation in current clinical practice. Congestive Heart Failure 5(1): 43-43, 2002

Relationship between the clinical picture and digoxin level in patients with heart failure in general practice. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1530-1533, 1974

Digoxin toxicity in Thai medical patients: clinical manifestations and an appropriate diagnostic serum level. Southeast Asian Journal of Tropical Medicine and Public Health 33(3): 608-612, 2003

Relationships between the clinical picture and digoxin level in general practice patients with cardiac insufficiency. Verhandlungen Der Deutschen Gesellschaft Fuer Innere Medizin: 530-1533, 1974

Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circulation. Heart Failure 2(2): 90-97, 2009

Study of the relationship between serum digoxin level toxicity and serum digoxin level clinical efficiency in elderly people. Therapie (London/Paris) 40(6): 469-473, 1985

Quinidine-induced digoxin toxicity after discontinuing digoxin in a patient with renal failure. Clinical Pharmacy 3(6): 662-664, 1984

Effect of hemo perfusion on serum digoxin level and cardio toxicity in digoxin intoxication. Kidney International 21(1): 154, 1982

Combination treatment with digoxin antibodies and plasmapheresis for the management of digoxin toxicity in a patient with renal failure. Farmacia Hospitalaria 37(2): 170-172, 2014

Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?. British Journal of Clinical Pharmacology 3(6): 1045-1051, 2012

Digoxin therapy of chronic cardiac failure under control of its concentration in the blood. Kardiologiia 21(4): 11-16, 1981